Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Study of the Effectiveness and Tolerability of Outpatient Titration of OxyContin for the Moderate and Severe Pain in Cancer Patients

NCT07869797 is registered in ClinicalTrials.gov with Mundipharma (China) Pharmaceutical Co. Ltd as lead sponsor.

NCT NCT07869797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07869797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Study of the Effectiveness and Tolerability of Outpatient Titration of OxyContin for the Moderate and Severe Pain in Cancer Patients
Lead sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
April 30, 2027
Enrollment
378 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

cancer pain